CVX Carvolix SA

4.958USD4.520 EUR · EPA-3.21%Mkt Cap: 308.51M USDP/E: —

Carvolix SA, a medical technology company, develops and markets minimally invasive, minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mecha…

Key Statistics

Company
Market Cap308.51M USD
Enterprise Value322.16M USD
Revenue (TTM)1.74M USD
Gross Profit938.86K USD
Net Income (TTM)-16.17M USD
Revenue/Share0.04 USD
Last Price4.958 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees102
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013333077
Valuation
P/E (Trailing)—
P/E (Forward)-9.94
PEG—
EV/EBITDA-15.05
EV/Revenue184.73
P/S176.91
P/B6.46
EPS (TTM)-0.70 USD
EPS (Forward)-0.50 USD
52W Range
1.45951% of range8.292
52W High8.292 USD
52W Low1.459 USD
Profitability
Gross Margin20.79%
Oper. Margin-1406.73%
EBITDA Margin0.00%
Profit Margin-357.92%
ROE-48.69%
ROA-24.22%
ROIC-36.26%
ROCE-28.52%
Growth
Revenue Growth119.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.42M USD
CapEx (TTM)161.23K USD
FCF Margin381.38%
FCF Yield2.16%
Net Debt13.66M USD
Net Debt/EBITDA-0.64
Net Debt/FCF2.05
Balance Sheet
Debt/Equity0.54
Current Ratio0.50
Quick Ratio0.44
Book Value/Sh0.77 USD
Cash/Share0.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.624 USD
Upside (mean)+94.1%
Target Range6.581 USD – 12.06 USD
6.581+94.1% to mean12.06
# Analysts4
Ownership
Shares Out.62.23M
Float3.26M
Insiders18.27%
Institutions65.62%
Technical
SMA 506.012 (-17.5%)
SMA 2004.941 (+0.3%)
Beta1.17
S&P 52W Chg12.00%
Avg Vol (30d)19.41K
Avg Vol (10d)22.32K
Technical Indicators
RSI (14)30.5
MACD-0.2585
MACD Signal-0.2002
MACD Hist.-0.0583
BB Upper6.596 USD
BB Middle5.674 USD
BB Lower4.752 USD
BB Width32.50%
ATR (14)0.2750 USD
Vol Ratio (20d)0.89x

About Carvolix (EPA: CVX)

›

Carvolix (EPA: CVX) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 102 employees.

The shares were at 4.520 EUR on 19 November 2026, up 197.4% over 52 weeks. Its 52-week range is 1.330 EUR to 7.560 EUR: the price is 40.2% below the high and 239.8% above the low.

Its market capitalisation is 281.28M EUR.

Carvolix reports return on equity of -48.7% and revenue up 119.6% year over year.

Its debt exceeds its cash by 12.46M EUR, a debt-to-equity ratio of 0.54. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 8.775 EUR is 94.1% above the current price.